$3.50
0.57% yesterday
Nasdaq, Aug 12, 10:00 pm CET
ISIN
US38246G1085
Symbol
GDRX

GoodRx Holdings Stock price

$3.50
-1.33 27.54% 1M
-1.33 27.54% 6M
-1.15 24.73% YTD
-3.28 48.38% 1Y
-3.86 52.45% 3Y
-29.50 89.39% 5Y
-29.50 89.39% 10Y
-29.50 89.39% 20Y
Nasdaq, Closing price Tue, Aug 12 2025
+0.02 0.57%

Key metrics

Basic
Market capitalization
$1.2b
Enterprise Value
$1.4b
Net debt
$189.9m
Cash
$301.0m
Shares outstanding
360.8m
Valuation (TTM | estimate)
P/E
43.5 | 8.8
P/S
1.5 | 1.5
EV/Sales
1.8 | 1.7
EV/FCF
17.9
P/B
1.9
Financial Health
Equity Ratio
52.2%
Return on Equity
2.3%
ROCE
6.5%
ROIC
4.8%
Debt/Equity
0.8
Financials (TTM | estimate)
Revenue
$797.4m | $836.2m
EBITDA
$151.8m | $282.6m
EBIT
$77.2m | $215.8m
Net Income
$28.5m | $142.7m
Free Cash Flow
$79.1m
Growth (TTM | estimate)
Revenue
4.3% | 5.5%
EBITDA
94.2% | 108.8%
EBIT
352.9% | 227.7%
Net Income
532.4% | 770.8%
Free Cash Flow
-8.6%
Margin (TTM | estimate)
Gross
93.8%
EBITDA
19.0% | 33.8%
EBIT
9.7%
Net
3.6% | 17.1%
Free Cash Flow
9.9%
More
EPS
$0.1
FCF per Share
$0.2
Short interest
6.2%
Employees
738
Rev per Employee
$1.1m
Show more

Is GoodRx Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

GoodRx Holdings Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a GoodRx Holdings forecast:

13x Buy
57%
9x Hold
39%
1x Sell
4%

Analyst Opinions

23 Analysts have issued a GoodRx Holdings forecast:

Buy
57%
Hold
39%
Sell
4%

Financial data from GoodRx Holdings

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
797 797
4% 4%
100%
- Direct Costs 49 49
21% 21%
6%
748 748
7% 7%
94%
- Selling and Administrative Expenses 468 468
4% 4%
59%
- Research and Development Expense 124 124
8% 8%
16%
152 152
94% 94%
19%
- Depreciation and Amortization 75 75
31% 31%
9%
EBIT (Operating Income) EBIT 77 77
353% 353%
10%
Net Profit 28 28
532% 532%
4%

In millions USD.

Don't miss a Thing! We will send you all news about GoodRx Holdings directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GoodRx Holdings Stock News

Neutral
Seeking Alpha
4 days ago
GoodRx Holdings, Inc. (NASDAQ:GDRX ) Q2 2025 Earnings Call August 7, 2025 8:00 AM ET Company Participants Aubrey Reynolds - Director of Investor Relations Christopher A. McGinnis - CFO & Treasurer Wendy Barnes - President, CEO & Director Conference Call Participants Charles Rhyee - TD Cowen, Research Division Daniel R.
Neutral
Business Wire
6 days ago
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its financial results for the second quarter of 2025. Second Quarter 2025 Highlights Revenue of $203.1 million Net income of $12.8 million; Net income margin of 6.3% Adjusted Net Income1 of $33.9 millio...
Neutral
Business Wire
16 days ago
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Laura Jensen as Chief Commercial Officer and President of Pharma Solutions, effective July 28, 2025. In this role, Laura will lead the company's Pharma Manufacturer Solutions offering and oversee strategic initiatives aimed at growing and enha...
More GoodRx Holdings News

Company Profile

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The firm offers information and tools to help consumers compare prices for prescription drugs. It operates applications and websites that provide prices and discounts at local and mail-order pharmacies. The company was founded in September 2015 and is headquartered in Santa Monica, CA.

Head office United States
CEO Wendy Barnes
Employees 738
Founded 2015
Website investors.goodrx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today